text.skipToContent text.skipToNavigation

 IMPORTANT UPDATE:  Some items may be delayed in shipping or out of stock due to extremely high demand.

Corning® Supersomes™ Human CYP1A2 + Oxidoreductase, 0.5 nmol

Product Number 456203
E-mail


Corning® Supersomes™ Human CYP1A2 + Oxidoreductase, 0.5 nmol Recombinant enzyme prepared from insect cells infected with baculovirus containing desired cDNAs

CYP1A2 is present in most human livers but its level of expression varies considerably among individuals. The levels of CYP1A2 are low or non-existent in non-hepatic tissues.

CYP1A2 is involved in the metabolism of 5-10% of commonly prescribed medications. Examples of drug substrates include acetaminophen, propranolol, naproxen, imipramine, amitriptyline, R-warfarin, clozapine, and several others. Common probe substrates used for CYP1A2 in vitro testing are phenacetin and 7-ethoxyresorufin; specific inhibitors include furafylline (MBI) and α-naphthoflavone.

CYP1A2 levels can be dramatically induced in the liver by compounds which can interact with the AHH-receptor complex, such as omeprazole, phenytoin, chronic smoking, and charcoal-broiled meat. CYP1A2 is involved in the activation of aromatic amine carcinogens, heterocyclic arylamine promutagens derived from food pyrolysates and aflatoxin B₁. CYP1A2 appears to be the high affinity form for aflatoxin B₁ activation in human liver.

  • Contains Human Oxidoreductase, but not cytochrome b₅
  • Available size: 0.5 nmole P450 in 0.5 mL
  • Protein concentration: Available in batch data sheet. Contact Corning Scientific support to obtain the information.



This product is non-returnable. If you have any questions, please contact us immediately.


$159.41 per each

Out of Stock

Details
Product Number   456203
Qty./Pk   1 / Pk  
Qty./Cs   1 / Ea  
Brand   Corning®  
Size   0.5 nmol  
Species   Human  
Enzyme Type   P450  
Protein Concentration   Lot-dependent  
Storage   -80°C  
Cellular Location   Microsome  
Specifications Documents